Table 2.
Repeated Measures Analysis: 12-Month Outcomes Comparing Life Goals Collaborative Care (LGCC) Versus Enhanced Treatment as Usual
| LGCC | Enhanced Treatment as Usual | Repeated Measures Analysisd | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N=65 | Baseline | 6 month | 12 month | Baseline | 6 month | 12 month | Beta | 95% CI | T | df | P | De | ||||||
| Cardiometabolic Risk | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||||||
| BMI | 33.2 | 6.1 | 32.8 | 6.7 | 32.6 | 5.5 | 37.2 | 7.9 | 36.6 | 9.2 | 36.5 | 10.4 | −.03 | −0.9, 0.9 | −.1 | 62 | .95 | −.04 |
| Waist circumference, in | 42.7 | 5.4 | 43.9 | 7.1 | 43.0 | 6.2 | 47.3 | 5.8 | 48.7 | 7.3 | 46.7 | 6.3 | −.29 | −1.4, 0.9 | −.5 | 62 | .61 | −.05 |
| Blood pressure-systolic mmHg | 130.2 | 13.3 | 134.9 | 13.1 | 134.5 | 17.5 | 137.5 | 24.1 | 132.8 | 15.8 | 135.3 | 19.0 | −.54 | −4.7, 3.6 | −.3 | 62 | .79 | −.02 |
| Blood pressure-diastolic mmHg | 84.0 | 10.0 | 84.9 | 12.3 | 83.2 | 12.7 | 86.2 | 12.1 | 84.6 | 13.2 | 84.1 | 11.7 | −.84 | −3.9, 2.2 | −.6 | 62 | .58 | −.07 |
| Quality of Lifea | ||||||||||||||||||
| SF-12 MCS | 30.1 | 7.4 | 32.5 | 7.4 | 33.2 | 5.5 | 29.7 | 6.4 | 31.5 | 7.9 | 31.0 | 6.6 | .03 | −1.9, 1.9 | .03 | 51 | .98 | .01 |
| SF-12 PCS | 34.8 | 7.7 | 34.8 | 7.0 | 36.0 | 8.8 | 36.8 | 8.7 | 35.5 | 7.2 | 34.3 | 7.1 | .85 | −1.1, 2.8 | .9 | 51 | .38 | .12 |
| Functioningb | 17.3 | 9.5 | 16.8 | 8.0 | 15.7 | 11.8 | 20.9 | 7.4 | 19.9 | 6.1 | 21.2 | 7.5 | −1.35 | −3.0, 0.3 | −1.6 | 59 | .11 | −.20 |
| Symptomsc | ||||||||||||||||||
| Depressive | 7.8 | 6.5 | 6.4 | 6.0 | 5.4 | 5.1 | 9.9 | 6.0 | 9.0 | 6.3 | 8.8 | 6.7 | −1.15 | −2.7, 0.4 | −1.5 | 61 | .15 | −.23 |
| Manic | 17.5 | 14.1 | 17.0 | 14.7 | 16.6 | 16.0 | 21.5 | 10.6 | 20.6 | 12.2 | 18.0 | 10.1 | −.64 | −3.7, 2.5 | −.4 | 59 | .68 | −.07 |
Health-related quality of life (SF-12) includes a mental health (MCS) and physical health component score (PCS). Possible scores range from 0 to 100, with higher scores indicating better health scores. For both summary scores, the population M ± SD is 50 ± 10.
Impaired functioning was assessed using the World Health Organization Disability Assessment Scale, a 12 item measure that assesses the degree of functional impairment experienced over the past month regarding self-care, mobility, cognition, social functioning, and role functioning, with possible scores ranging from 0 to 48 (higher scores indicating worse functioning).
Symptom scores were based on the Internal State Scale, an 8-item assessment of depressive and manic symptoms that are strongly correlated with clinician ratings. For depressive symptoms, possible scores range from 0 to 20. For manic symptoms, possible scores range from 0 to 50, Higher score indicate more severe symptoms.
Repeated measures analysis adjusted for the baseline value of the outcome, effect of the Life Goals Collaborative Care (LGCC), time (6, 12 months), and the interaction of time and LGCC effect.
Cohen’s D is a measure of effect size, with D >.3 indicating small to moderate effect